French Industry Rages Over €1.7bn Drug Savings Plan
This article was originally published in Scrip
Executive Summary
The French pharmaceutical industry has reacted angrily to a set of government cost-saving measures, including price cuts and sales rebates, that it says will cost it almost €1.7bn ($1.9bn) next year.